Insider · CIK 0001397636
Bernard Denoyer
Files at OKYO (OKYO Pharma Ltd). First filing -, latest -.
In brief
Bernard Denoyer files SEC Form 4 as director at OKYO (OKYO Pharma Ltd). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Bernard Denoyer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | OKYO OKYO Pharma Ltd | AGrant or award Optionderivative | +3,500 | $1.85 | $6,475 | 35,190 | Jun 10, 2026 |
Questions about Bernard Denoyer
Answered from the filings on this page, as of the latest one.
Is Bernard Denoyer buying or selling?
Bernard Denoyer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Bernard Denoyer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bernard Denoyer has 0.
Where does Bernard Denoyer file Form 4?
Bernard Denoyer has filed Form 4 at OKYO (OKYO Pharma Ltd). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.